24 May 2013
Keywords: chmp, gives, nod, wyeth, conbriza, fresenius, removab
Article | 02 March 2009
At its February meeting, the European Medicines Agency's (EMEA) Committee for Medicinal Products for Human Use (CHMP) adopted positive
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
2 March 2009
23 May 2013
© 2013 thepharmaletter.com